Dianthus Therapeutics (DNTH) Misses Q1 EPS by 85c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.85). Revenue for the quarter came in at $460 thousand.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• CNB Community Bancorp, Inc. (CNBB) Declares $0.34 Quarterly Dividend; 2.8% Yield
• Schwab's May activity shows margin loans nearly double